You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

Litigation Details for Indivior Inc. v. Biodelivery Sciences International, Inc. (E.D.N.C. 2015)

✉ Email this page to a colleague

« Back to Dashboard

Indivior Inc. v. Biodelivery Sciences International, Inc. (E.D.N.C. 2015)

Docket	⤷ Sign Up	Date Filed	2015-07-21
Court	District Court, E.D. North Carolina	Date Terminated	2023-03-09
Cause	35:271 Patent Infringement	Assigned To	James C. Dever III
Jury Demand	Both	Referred To
Parties	QUINTILES COMMERCIAL US, INC.
Patents	6,159,498; 7,579,019; 8,147,866; 8,603,514; 8,703,177; 8,765,167; 9,522,188; 9,655,843; 9,931,305
Attorneys	Oren Langer
Firms	TROUTMAN SANDERS, LLP, Post Office
Link to Docket	External link to docket

Small Molecule Drugs cited in Indivior Inc. v. Biodelivery Sciences International, Inc.

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Details for Indivior Inc. v. Biodelivery Sciences International, Inc. (E.D.N.C. 2015)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2021-11-17	101	Opening Claim Construction Brief	Indivior Inc.. (Attachments: # 1 Exhibit A - Patent 8,765,167, # 2 Exhibit B - Pather Declaration, # 3 Exhibit… Exhibit E - Patent 5,881,476, # 6 Exhibit F - Rounds Declaration, # 7 Exhibit G - Patent 5,393,528, #…2010 Response to Office Action, # 9 Exhibit I - Patent 7,425,292) (Evans, E.) (Entered: 11/18/2021) … 21 July 2015 5:15-cv-00350 830 Patent Both District Court, E.D. North Carolina	External link to document
2021-12-16	103	Responsive Claim Construction Brief	U.S. Patent 8,603,514 B2, # 4 Exhibit M - U.S. Patent 8,900,497 B2, # 5 Exhibit N - U.S. Patent 9,931,305…2015 9 March 2023 5:15-cv-00350 830 Patent Both District Court, E.D. North Carolina	External link to document
2022-07-28	109	Exhibit Q - 2022.02.19 Gelwicks Email	1 Index of Exhibits, # 2 Exhibit A - U.S. Patent 8,765,167, # 3 Exhibit B - Aquestive's First Set of …identified by the patent claimant in its Local Civil Rule 303.1(c) chart,’ as required by Local Patent rule 303.4…identified by the patent claimant in its Local Civil Rule 303.1(c) chart,” as required by Local Patent rule 303.4…best, a fundamental misunderstanding of the local patent rules, or, at worst, a flagrant violation of those…document production clearly satisfies the local patent rules. Each of the claims charted in Plaintiffs	External link to document
2015-07-21	27		infringement of a patent related to Suboxone, U.S. Patent No. 8,765,167 (the “’167 patent”). (Pls.’ Opp’n…making it. (Ia'. il 15; Ex. A-l, U.S. Patent No. 8,765,167, Abstract (filed Sep. 8, 2006), ECF No. …’832 Patent or U.S. Patent No. 7,897,080 (the “’08() Patent”).4 (Ia'. il 7.) The ’080 Patent is owned…alleged that Bunavail infringed U.S. Patent No. 8,4752832 (the “’832 Patent”). (Ic!. iiil 42-5 l .) RBP and…exclusive licensees of the Patent. (Chiistie Decl., Ex. 5 il 9.) The ’832 Patent is entitled “Sublingual	External link to document
2016-05-06	42		proceedings concerning U.S. Patent No. 8,765,167 at the United States Patent and Trademark Office, including… non-appealable decision concerning U.S. Patent No. 8,765,167. Signed by Chief Judge James C. Dever III…non- appealable decision concerning U.S. Patent No. 8,765,167. 3. The motion to dismiss [D.E. … 21 July 2015 5:15-cv-00350 830 Patent Both District Court, E.D. North Carolina	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.